Doctor profile · Federal record

Dr. Kelly Parling-Lynch, DO

Medical Oncology Physician (CMS: Hematology/Oncology) · Norton Shores, MI

  • NPI 1215936158
  • Accepts Medicare
  • MIPS 89.4 / 100 · 2023
  • 27 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
6425 S. Harvey St
Norton Shores, MI 494449739
(231) 737-3469
fax (231) 737-4548
Mailing address
5800 Foremost Dr Se Ste 300
Grand Rapids, MI 495467062

Credentials & registration

NPPES · NUCC
NPI registered
July 2005 — 21 yrs on file
Profile last updated
March 13, 2020
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Michigan #5101014119

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1215936158. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
42,240
Distinct HCPCS
10
Medicare allowed
$224,827
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 18,000 17 $1
J9267 Injection, paclitaxel, 1 mg 9,456 11 $0
J1453 Injection, fosaprepitant, 1 mg 4,200 11 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,752 42 $0
36415 Insertion of needle into vein for collection of blood sample 1,119 195 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,071 183 $8
J2469 Injection, palonosetron hcl, 25 mcg 990 27 $1
80053 Blood test, comprehensive group of blood chemicals 670 148 $10
J1626 Injection, granisetron hydrochloride, 100 mcg 520 11 $0
96375 Injection of additional new drug or substance into vein 509 51 $14

In context: peer comparison

Among 1 peers in this city , average services per provider: 741. This provider delivers 57× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,363
Transactions
103
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Genentech USA, Inc. 18 $273.62
GlaxoSmithKline, LLC. 7 $216.20
Merck Sharp & Dohme LLC 8 $209.39
AstraZeneca Pharmaceuticals LP 7 $186.33
Daiichi Sankyo Inc. 5 $181.69
ABBVIE INC. 9 $169.93
E.R. Squibb & Sons, L.L.C. 7 $169.02
Celgene Corporation 12 $168.67
EMD Serono, Inc. 4 $151.44
Janssen Biotech, Inc. 5 $107.55
PFIZER INC. 6 $98.77
JAZZ PHARMACEUTICALS INC. 3 $90.14
Eisai Inc. 4 $86.59
Lilly USA, LLC 4 $82.15
Novartis Pharmaceuticals Corporation 4 $79.74

By nature of payment

Food and Beverage
$3,345
Education
$18

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,437
Patients
519
Total drug cost
$999,534
Drug Type Claims Patients Total cost
Letrozole Generic 199 60 $12,863
Prochlorperazine Maleate Generic 182 108 $2,798
Acyclovir Generic 156 39 $2,839
Prednisone Generic 134 50 $683
Dexamethasone Generic 132 46 $1,794
Anastrozole Generic 93 30 $4,577
Tamoxifen Citrate Generic 91 27 $4,627
Hydroxyurea Generic 74 17 $2,476
Levothyroxine Sodium Generic 65 21 $1,117
Olanzapine Generic 56 26 $203

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Kelly Parling-Lynch's medical specialty?
Dr. Kelly Parling-Lynch practices Medical Oncology Physician in Norton Shores, MI.
Where does Dr. Kelly Parling-Lynch practice?
Dr. Kelly Parling-Lynch practices at 6425 S. Harvey St, Norton Shores, MI 494449739. Office phone: 2317373469.
What is Dr. Kelly Parling-Lynch's NPI?
Dr. Kelly Parling-Lynch's National Provider Identifier (NPI) is 1215936158, issued by NPPES.
Does Dr. Kelly Parling-Lynch accept Medicare assignment?
Yes. Dr. Kelly Parling-Lynch accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kelly Parling-Lynch commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, paclitaxel, 1 mg (HCPCS J9267); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.